267 related articles for article (PubMed ID: 36265833)
1. Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality.
Al-Taie A; Büyük AŞ; Sardas S
Pulm Pharmacol Ther; 2022 Dec; 77():102172. PubMed ID: 36265833
[TBL] [Abstract][Full Text] [Related]
2. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.
Muyambo S; Ndadza A; Soko ND; Kruger B; Kadzirange G; Chimusa E; Masimirembwa CM; Ntsekhe M; Nhachi CFB; Dandara C
OMICS; 2022 Jan; 26(1):35-50. PubMed ID: 34958284
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics and Personalized Medicine.
Cecchin E; Stocco G
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics for Clinical Trials of COVID-19 Medicines: Why Is This Important Now?
Şardaş S; Özdemir V
OMICS; 2021 Nov; 25(11):679-680. PubMed ID: 34699259
[No Abstract] [Full Text] [Related]
6. Report on the pharmacogenomics and personalized medicine 2011 conference: part 1.
Harrison N
Pharmacogenomics; 2012 Jan; 13(2):141-5. PubMed ID: 22256866
[TBL] [Abstract][Full Text] [Related]
7. Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.
Valgus J; Weitzel KW; Peterson JF; Crona DJ; Formea CM
Am J Health Syst Pharm; 2019 Apr; 76(8):521-529. PubMed ID: 31361863
[TBL] [Abstract][Full Text] [Related]
8. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
10. Variability of Pharmacogenomics Information in Drug Labels Approved by Different Agencies and its Ethical Implications.
Güner MD; Ekmekci PE; Kurtoglu B
Curr Drug Saf; 2022; 17(1):47-53. PubMed ID: 34315387
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenomics: precision tool in routine prescription].
Yu B
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1143-1148. PubMed ID: 33172545
[TBL] [Abstract][Full Text] [Related]
12. Some applications of pharmacogenomics and epigenetics in drug development and use in pursuit of personalized medicine.
Powanda MC; Moyer ED
Inflammopharmacology; 2012 Oct; 20(5):245-50. PubMed ID: 22773313
[TBL] [Abstract][Full Text] [Related]
13. Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.
Becquemont L; Alfirevic A; Amstutz U; Brauch H; Jacqz-Aigrain E; Laurent-Puig P; Molina MA; Niemi M; Schwab M; Somogyi AA; Thervet E; Maitland-van der Zee AH; van Kuilenburg AB; van Schaik RH; Verstuyft C; Wadelius M; Daly AK
Pharmacogenomics; 2011 Jan; 12(1):113-24. PubMed ID: 21174626
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics in Cardiovascular Medicine.
Weeke PE
Adv Pharmacol; 2018; 83():333-360. PubMed ID: 29801582
[TBL] [Abstract][Full Text] [Related]
15. The Long View on COVID-19 Theranostics and Oral Antivirals: Living with Endemic Disease and Lessons from Molnupiravir.
Al-Taie A; Denkdemir FR; Sharief Z; Buyuk AS; Şardaş S
OMICS; 2022 Jun; 26(6):324-328. PubMed ID: 35580151
[TBL] [Abstract][Full Text] [Related]
16. [The pharmacogenetics as integral part of personalized medicine: problems and prospects].
Amlaev KR; Khripunova AA; Maksimenko LL; Khripunova IG; Maksimenko EV; Stepanyan TO
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2024 Mar; 32(2):173-179. PubMed ID: 38640209
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the current level of pharmacists' pharmacogenomics knowledge and its impact on pharmacogenomics implementation.
Nagy M; Tsermpini EE; Siamoglou S; Patrinos GP
Pharmacogenomics; 2020 Nov; 21(16):1179-1189. PubMed ID: 33118449
[TBL] [Abstract][Full Text] [Related]
18. Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude.
Wang LY; Cui JJ; OuYang QY; Zhan Y; Wang YM; Xu XY; Yu LL; Yin H; Wang Y; Luo CH; Guo CX; Yin JY
EPMA J; 2021 Sep; 12(3):307-324. PubMed ID: 34306260
[TBL] [Abstract][Full Text] [Related]
19. Developments in pharmacogenetics, pharmacogenomics, and personalized medicine.
Abad-Santos F; Aliño SF; Borobia AM; García-Martín E; Gassó P; Maroñas O; Agúndez JAG
Pharmacol Res; 2024 Feb; 200():107061. PubMed ID: 38199278
[TBL] [Abstract][Full Text] [Related]
20. European Medicines Agency initiatives and perspectives on pharmacogenomics.
Ehmann F; Caneva L; Papaluca M
Br J Clin Pharmacol; 2014 Apr; 77(4):612-7. PubMed ID: 24433361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
